152 related articles for article (PubMed ID: 30588338)
1. A two-microRNA-based signature predicts first-line chemotherapy outcomes in advanced colorectal cancer patients.
Lu JH; Zuo ZX; Wang W; Zhao Q; Qiu MZ; Luo HY; Chen ZH; Mo HY; Wang F; Yang DD; Wang Y; Wei XL; Wu QN; Ju HQ; Xu RH; Zeng ZL
Cell Death Discov; 2018; 4():116. PubMed ID: 30588338
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
[TBL] [Abstract][Full Text] [Related]
3. Plasma exosomal microRNA-125b as a monitoring biomarker of resistance to mFOLFOX6-based chemotherapy in advanced and recurrent colorectal cancer patients.
Yagi T; Iinuma H; Hayama T; Matsuda K; Nozawa K; Tsukamoto M; Shimada R; Akahane T; Tsuchiya T; Ozawa T; Hashiguchi Y
Mol Clin Oncol; 2019 Oct; 11(4):416-424. PubMed ID: 31497299
[TBL] [Abstract][Full Text] [Related]
4. Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation.
Chen X; Shi K; Wang Y; Song M; Zhou W; Tu H; Lin Z
Oncotarget; 2015 Nov; 6(35):37544-56. PubMed ID: 26462034
[TBL] [Abstract][Full Text] [Related]
5. A 4-microRNA signature predicts lymph node metastasis and prognosis in breast cancer.
Chen X; Wang YW; Zhu WJ; Li Y; Liu L; Yin G; Gao P
Hum Pathol; 2018 Jun; 76():122-132. PubMed ID: 29555574
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a novel miRNA classifier as a prognostic signature for stage II/III colorectal cancer.
Feng J; Wei Q; Yang M; Wang X; Liu B; Li J
Ann Transl Med; 2021 May; 9(9):747. PubMed ID: 34268360
[TBL] [Abstract][Full Text] [Related]
7. A 3-MicroRNA Signature Identified From Serum Predicts Clinical Outcome of the Locally Advanced Gastric Cancer.
Chen S; Lao J; Geng Q; Zhang J; Wu A; Xu D
Front Oncol; 2020; 10():565. PubMed ID: 32656071
[No Abstract] [Full Text] [Related]
8. A Five-microRNA Signature as Prognostic Biomarker in Colorectal Cancer by Bioinformatics Analysis.
Yang G; Zhang Y; Yang J
Front Oncol; 2019; 9():1207. PubMed ID: 31799184
[TBL] [Abstract][Full Text] [Related]
9. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W
Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study.
Tang XR; Li YQ; Liang SB; Jiang W; Liu F; Ge WX; Tang LL; Mao YP; He QM; Yang XJ; Zhang Y; Wen X; Zhang J; Wang YQ; Zhang PP; Sun Y; Yun JP; Zeng J; Li L; Liu LZ; Liu N; Ma J
Lancet Oncol; 2018 Mar; 19(3):382-393. PubMed ID: 29428165
[TBL] [Abstract][Full Text] [Related]
11. Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections.
Marchini S; Cavalieri D; Fruscio R; Calura E; Garavaglia D; Fuso Nerini I; Mangioni C; Cattoretti G; Clivio L; Beltrame L; Katsaros D; Scarampi L; Menato G; Perego P; Chiorino G; Buda A; Romualdi C; D'Incalci M
Lancet Oncol; 2011 Mar; 12(3):273-85. PubMed ID: 21345725
[TBL] [Abstract][Full Text] [Related]
12. A Distinctive microRNA (miRNA) Signature in the Blood of Colorectal Cancer (CRC) Patients at Surgery.
Gasparello J; Papi C; Allegretti M; Giordani E; Carboni F; Zazza S; Pescarmona E; Romania P; Giacomini P; Scapoli C; Gambari R; Finotti A
Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32854257
[TBL] [Abstract][Full Text] [Related]
13. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
[TBL] [Abstract][Full Text] [Related]
14. A Novel Saliva-Based miRNA Signature for Colorectal Cancer Diagnosis.
Rapado-González Ó; Majem B; Álvarez-Castro A; Díaz-Peña R; Abalo A; Suárez-Cabrera L; Gil-Moreno A; Santamaría A; López-López R; Muinelo-Romay L; Suarez-Cunqueiro MM
J Clin Med; 2019 Nov; 8(12):. PubMed ID: 31757017
[TBL] [Abstract][Full Text] [Related]
15. Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05).
Joerger M; Baty F; Früh M; Droege C; Stahel RA; Betticher DC; von Moos R; Ochsenbein A; Pless M; Gautschi O; Rothschild S; Brauchli P; Klingbiel D; Zappa F; Brutsche M
Lung Cancer; 2014 Aug; 85(2):306-13. PubMed ID: 24928469
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs Expression Patterns Predict Tumor Mutational Burden in Colorectal Cancer.
Huang J; Liu H; Zhao Y; Luo T; Liu J; Liu J; Pan X; Tang W
Front Oncol; 2020; 10():550986. PubMed ID: 33634010
[TBL] [Abstract][Full Text] [Related]
17. Circulating microRNA expressions in colorectal cancer as predictors of response to chemotherapy.
Zhang J; Zhang K; Bi M; Jiao X; Zhang D; Dong Q
Anticancer Drugs; 2014 Mar; 25(3):346-52. PubMed ID: 24304648
[TBL] [Abstract][Full Text] [Related]
18. Prediction of radiotherapy response with a 5-microRNA signature-based nomogram in head and neck squamous cell carcinoma.
Chen L; Wen Y; Zhang J; Sun W; Lui VWY; Wei Y; Chen F; Wen W
Cancer Med; 2018 Mar; 7(3):726-735. PubMed ID: 29473326
[TBL] [Abstract][Full Text] [Related]
19. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer.
Hur K; Toiyama Y; Schetter AJ; Okugawa Y; Harris CC; Boland CR; Goel A
J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25663689
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of miRNA-148a and miRNA-625-3p in colorectal cancer is associated with tumor budding.
Baltruskeviciene E; Schveigert D; Stankevicius V; Mickys U; Zvirblis T; Bublevic J; Suziedelis K; Aleknavicius E
BMC Cancer; 2017 Sep; 17(1):607. PubMed ID: 28863773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
